Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Marine Natural Product Drug Discovery through Microfluidic Encapsulation | Grant | 10,000.00 | Research | Christopher Cartmell | Pharmacology | American Society of Pharmacognosy | 05/2024 |
| MR-Guided Precision Conformal Ablation Therapy for Brain Tumors | Grant | 171,949.00 | Research | Julie Pilitsis | Neurosurgery | Worcester Polytechnic Institute | 05/2024 |
| Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimers Disease Risk | Grant | 3,879.00 | Research | Michael Grandner | Psychiatry | University of Utah | 05/2024 |
| Patterns of Survivors' Recovery Trajectories in the ICECAP trial POST-ICECAP | Contract | * | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | University of Michigan | 05/2024 |
| Post-Transcriptional Regulation of Gene Expression by Ribosome-Binding Protein 1 | Grant | 3,671,336.00 | Research | Shirin Doroudgar | COM Phx Trans Cardio Rsrch Ctr | National Heart, Lung, and Blood Institute | 05/2024 |
| Postdoctoral Research Mentoring for the Indiana Minority Health Coalition | Contract | 67,847.00 | Other Sponsored Activity | Beth Meyerson | Family and Community Medicine | Indiana Minority Health Coalition, Inc. | 05/2024 |
| PREVENT - Practice-based Approaches to Promote HPV Vaccination | Grant | 32,385.00 | Research | Gloria Coronado | Epidemiology and Biostatistics | University of Utah | 05/2024 |
| RECOVER Clinical Trials Data Coordinating Center Initiative - SLEEP Clinical Trial | Grant | 86,054.00 | Research | Sairam Parthasarathy | Medicine | Duke University | 05/2024 |
| Roles for SGK1 in Cardiometabolic Heart Failure with Preserved Ejection Fraction | Grant | 225,000.00 | Research | Erik Blackwood | COM Phx Trans Cardio Rsrch Ctr | Arizona Biomedical Research Centre | 05/2024 |
| Screening More Patients for CRC Through Adapting and Refining Targeted Evidence-based Interventions in Rural Settings (SMARTER CRC) | Grant | 70,179.00 | Research | Gloria Coronado | Epidemiology and Biostatistics | Oregon Health and Science University | 05/2024 |
| Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) | Grant | 200,066.00 | Research | Bettina Cuneo | Surgery | New York University | 05/2024 |
| Targeting Inflammation and Oxidative Stress to Treat Acute Lung Injury With CNP-miR146a | Grant | 124,792.00 | Research | Geoffrey Gurtner | Surgery | Ceria Therapeutics | 05/2024 |
| Targeting P53-Mutated Head and Neck Squamous Cell Carcinoma | Grant | 749,993.00 | Research | Carlos Caulin | Otolaryngology | Arizona Biomedical Research Centre | 05/2024 |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | Cooperative Agreement | 29,876.00 | Research | Roderick Tung | COM Phx Internal Medicine | Northwestern University | 05/2024 |
| University of Arizona - Title V Needs Assessment | Contract | 232,000.00 | Other Sponsored Activity | John Ehiri | Public Health Administration | Arizona Department of Health Services | 05/2024 |
| A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase 1 Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527 | Contract | * | Clinical Trial | Jennifer Segar | Cancer Center Division | Aptevo Therapeutics Inc | 04/2024 |
| A Multi-Center, Phase IIA, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects | Contract | * | Clinical Trial | Scott Sherman | Neurology | PharmaTher Inc (Canada) | 04/2024 |
| A Phase 1/2, Safety Lead-in and Dose Expansion, Open-label, Multicenter Trial Investigating the Safety,Tolerability, and Preliminary Activity of Ivosidenib in Combination with Nivolumab and Ipilimumab | Contract | * | Clinical Trial | Rachna Shroff | Cancer Center Division | Servier Pharmacueticals | 04/2024 |
| A Phase 2, multicenter, Open-Label, Long-Term Safety Study of LP352 in Subjects with Developmental and Epileptic Encephalopathy who Completed Study LP352-201 and are Candidates for Continuous Treatmen | Contract | * | Clinical Trial | David Labiner | Neurology | Longboard Pharmaceuticals, Inc. | 04/2024 |
| A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients | Contract | * | Clinical Trial | Aaron Scott | Cancer Center Division | Cardiff Oncology, Inc. | 04/2024 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.